Signaling, polyubiquitination, trafficking, and inclusions: Sequestosome 1/p62's role in neurodegenerative disease

Journal of Biomedicine and Biotechnology

Volumn 2006, Issue , 2006, Pages

  Wooten, Marie W ^a   Hu, Xiao ^a   Babu, J Ramesh ^a   Seibenhener, M Lamar ^a   Geetha, Thangiah ^a   Paine, Michael G ^a   Wooten, Michael C ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; PROTEASOME; PROTEIN P62; SEQUESTOSOME 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOPHAGY; CELL INCLUSION; CHRONIC DISEASE; DEGENERATIVE DISEASE; DISEASE MARKER; DRUG TARGETING; HUMAN; LYSOSOME; NONHUMAN; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 33746805387     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/JBB/2006/62079     Document Type: Review

References (87)

1. D H Wolf From lysosome to proteasome: the power of yeast in the dissection of proteinase function in cellular regulation and waste disposal. Cellular and Molecular Life Sciences 61 2004 13 1601 1614
2. U Schubert L C Antón J Gibbs C C Norbury J W Yewdell jyewdell@nih.gov J R Bennink jbennink@nih.gov Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404 2000 6779 770 774
3. S JS Berke sarah-berke@uiowa.edu H L Paulson henry-paulson@uiowa.edu Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Current Opinion in Genetics and Development 13 2003 3 253 261
4. R R Kopito kopito@stanford.edu Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biology 10 2000 12 524 530
5. A Alves-Rodrigues L Gregori M E Figueiredo-Pereira Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends in Neurosciences 21 1998 12 516 520
6. I Lang-Rollin H Rideout L Stefanis LS76@columbia.edu Ubiquitinated inclusions and neuronal cell death. Histology and Histopathology 18 2003 2 509 517
7. S Jentsch jentsch@biochem.mpg.de G Pyrowolakis Ubiquitin and its kin: how close are the family ties? Trends in Cell Biology 10 2000 8 335 342
8. C M Pickart cpickart@jhmi.edu M J Eddins Ubiquitin: structures, functions, mechanisms. Biochimica et Biophysica Acta 1695 2004 1-3 55 72
9. C M Pickart Ubiquitin in chains. Trends in Biochemical Sciences 25 2000 11 544 548
10. J Peng D Schwartz J E Elias A proteomics approach to understanding protein ubiquitination. Nature Biotechnology 21 2003 8 921 926
11. R M Hofmann C M Pickart In vitro assembly and recognition of Lys-63 polyubiquitin chains. Journal of Biological Chemistry 276 2001 30 27936 27943
12. M H Glickman A Ciechanover The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews 82 2002 2 373 428
13. A M Weissman Themes and variations on ubiquitylation. Nature Reviews Molecular and Cell Biology 2 2001 169 178
14. L Hicke H L Schubert C P Hill Ubiquitin-binding domains. Nature Reviews Molecular Cell Biology 6 2005 610 621
15. K Wu A Chen P Tan Z-Q Pan zhen-qiang.pan@mssm.edu The Nedd8-conjugated ROC1-CUL1 core ubiquitin ligase utilizes Need8 charged surface residues for efficient polyubiquitin chain assembly catalyzed by Cdc34. Journal of Biological Chemistry 277 2002 1 516 527
16. K Ferrell C RM Wilkinson W Dubiel wolfgang.dubiel@charite.de C Gordon colin.gordon@hgu.mrc.ac.uk Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends in Biochemical Sciences 25 2002 2 83 88
17. J W Yewdell Immunoproteasomes: regulating the regulator. Proceedings of the National Academy of Sciences of the United States of America 102 2005 26 9089 9090
18. S Heink D Ludwig P-M Kloetzel E Krüger elke.krueger@charite.de IFN-γ-induced immune adaptation of the proteasome system is an accelerated and transient response. Proceedings of the National Academy of Sciences of the United States of America 102 2005 26 9241 9246
19. P-M Kloetzel p-m.Kloetzel@charite.de F Ossendorp f.a.ossendorp@lumc.nl Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Current Opinion in Immunology 16 2004 1 76 81
20. C Cheroni M Peviani P Cascio S DeBiasi C Monti C Bendotti bendotti@marionegri.it Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiology of Disease 18 2005 3 509 522
21. M Diaz-Hernandez F Hernandez E Martin-Aparicio Neuronal induction of the immuno-proteasome in Huntington's disease. The Journal of Neuroscience 23 2003 37 11653 11661
22. R Hartmann-Petersen C Gordon Proteins interacting with the 26S proteasome. Cellular and Molecular Life Sciences 61 2004 13 1589 1595
23. M L Seibenhener J R Babu T Geetha H C Wong N R Krishna M W Wooten Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Molecular and Cellular Biology 24 2004 18 8055 8068
24. A Kanayama R B Seth L Sun TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Molecular Cell 15 2004 4 535 548
25. T D Mueller M Kamionka J Feigon feigon@mbi.ucla.edu Specificity of the interaction between ubiquitin-associated domains and ubiquitin. Journal of Biological Chemistry 279 2004 12 11926 11936
26. K Madura maduraki@umdnj.edu The ubiquitin-associated (UBA) domain: on the path from prudence to prurience. Cell Cycle 1 2002 4 235 244
27. K M Donaldson W Li K A Ching S Batalov C-C Tsai C AP Joazeiro joazeiro@gnf.org Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proceedings of the National Academy of Sciences of the United States of America 100 2003 15 8892 8897
28. R Hartmann-Petersen C Gordon Ubiquitin-proteasome system: proteins interacting with the 26S proteasome. Cellular and Molecular Life Sciences 61 2004 13 1589 1595
29. S Elsasser R R Gali M Schwikart Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nature Cell Biology 4 2002 9 725 730
30. H Rao raoh@cco.caltech.edu A Sastry Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23. Journal of Biological Chemistry 277 2002 14 11691 11695
31. R Verma R Oania J Graumann R J Deshaies deshaies@caltech.edu Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118 2004 1 99 110
32. E W Doss-Pepe E S Stenroos W G Johnson K Madura Ataxin-3 interactions with Rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Molecular and Cellular Biology 23 2003 18 6469 6483
33. R Varadan O Walker C M Pickart D Fushman fushman@wam.umd.edu Structural properties of polyubiquitin chains in solution. Journal of Molecular Biology 324 2002 4 637 647
34. S Raasi R Varadan D Fushman C M Pickart Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nature Structural and Molecular Biology 12 2005 8 708 714
35. J A Johnston C L Ward R R Kopito Aggresomes: a cellular response to misfolded proteins. Journal of Cell Biology 143 1998 7 1883 1898
36. H C Ardley h.c.ardley@leeds.ac.uk G B Scott S A Rose N GS Tan A F Markham P A Robinson Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing parkin. Molecular Biology of the Cell 14 2003 11 4541 4556
37. D-H Hyun Divisionpharm@kcl.ac.uk M Lee B Halliwell P Jenner Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. Journal of Neurochemistry 86 2003 2 363 373
38. N F Bence R M Sampat R R Kopito Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 2001 5521 1552 1555
39. E J Bennett N F Bence R Jayakumar R R Kopito Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Molecular Cell 17 2005 3 351 365
40. R Garcia-Mata Y-S Gao E Sztul esztul@cellbio.bhs.uab.edu Hassles with taking out the garbage: aggravating aggresomes. Traffic 3 2002 6 388 396
41. J P Taylor taylorjp@ninds.nih.gov F Tanaka J Robitschek Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Human Molecular Genetics 12 2003 7 749 757
42. R J Ellis jellis@bio.warwick.ac.uk T JT Pinheiro Danger-misfolding proteins. Nature 416 2002 6880 483 484
43. C M Dobson cmd44@cam.ac.uk Principles of protein folding, misfolding and aggregation. Seminars in Cell and Developmental Biology 15 2004 1 3 16
44. M Arrasate S Mitra E S Schweitzer M R Segal S Finkbeiner sfinkbeiner@gladstone.ucsf.edu Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 2004 7010 805 810
45. A Ciechanover c_tzachy@netvision.net.il P Brundin patrik.brundin@neurol. lu.se The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40 2003 2 427 446
46. Y Imai M Soda R Takahashi ryosuke@brain.riken.go.jp Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. Journal of Biological Chemistry 275 2000 46 35661 35664
47. E Sakata Y Yamaguchi E Kurimoto Parkin binds the Rpn 10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Reports 4 2003 3 301 306
48. J Hardy D J Selkoe selkoe@cnd.bwh.harvard.edu The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 2002 5580 353 356
49. J R Babu T Geetha M W Wooten Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. Journal of Neurochemistry 94 2005 1 192 203
50. M R Nichols M A Moss D K Reed J H Hoh T L Rosenberry Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers. Biochemistry 44 2005 1 165 173
51. L J Liao D M Cheng J Wang Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. Journal of Biological Chemistry 279 2004 35 37061 37068
52. B Ciani R Layfield robert.layfield@nottingham.ac.uk J R Cavey P W Sheppard M S Searle mark.searle@nottingham.ac.uk Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. Journal of Biological Chemistry 278 2003 39 37409 37412
53. T Geetha M W Wooten Structure and functional properties of the ubiquitin binding protein p62. FEBS Letters 512 2002 1-3 19 24
54. D M Janse B Crosas D Finley G M Church g1m1c1@arep.med.harvard.edu Localization to the proteasome is sufficient for degradation. Journal of Biological Chemistry 279 2004 20 21415 21420
55. T Geetha J R Babu J Peng M W Wooten Sequestosome 1/p62 involved in ubiquitin proteasome degradation of the nerve growth factor receptor TrkA. In press
56. S Capsoni G Ugolini A Comparini F Ruberti N Berardi A Cattaneo cattaneo@sissa.it Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 97 2000 12 6826 6831
57. S E Counts E J Mufson emufson@rush.edu The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. Journal of Neuropathology and Experimental Neurology 64 2005 4 263 272
58. T Lamark M Perander H Outzen Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. Journal of Biological Chemistry 278 2003 36 34568 34581
59. M G Paine J R Babu M L Seibenhener M W Wooten Evidence for p62 aggregate formation: role in cell survival. FEBS Letters 579 2005 22 5029 5034
60. E Kuusisto A Salminen I Alafuzoff Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. NeuroReport 12 2001 10 2085 2090
61. R K Vadlamudi J Shin shin@mbcrr.harvard.edu Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein. FEBS Letters 435 1998 2-3 138 142
62. E Kuusisto T Suuronen A Salminen antero.salminen@uku.fi Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochemical and Biophysical Research Communications 280 2001 1 223 228
63. K Nakaso kazuhiro@grape.med.tottori-u.ac.jp Y Yoshimoto T Nakano Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease. Brain Research 1012 2004 1-2 42 51
64. M W Wooten T Geetha M L Seibenhener J R Babu M T Diaz-Meco J Moscat The p62 scaffold regulates nerve growth factor-induced NF-κB activation by influencing TRAF6 polyubiquitination. Journal of Biological Chemistry 280 2005 42 35625 35629
65. S Chang J H Kim J Shin jkshin@med.skku.ac.kr p62 forms a ternary complex with PKCζ and PAR-4 and antagonizes PAR-4-induced PKCζ inhibition. FEBS Letters 510 2002 1-2 57 61
66. I Joung ijoung@hanseo.ac.kr H J Kim Y K Kwon kimyh@khu.ac.kr p62 modulates Akt activity via association with PKCζ in neuronal survival and differentiation. Biochemical and Biophysical Research Communications 334 2005 2 654 660
67. J Xie Q Guo PAR-4 is involved in regulation of β-secretase cleavage of the Alzheimer amyloid precursor protein. Journal of Biological Chemistry 280 2005 14 13824 13832
68. T Grune T Jung K Merker K JA Davies Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and "aggresomes" during oxidative stress, aging, and disease. International Journal of Biochemistry and Cell Biology 36 2004 12 2519 2530
69. G DJ Watts J Wymer M J Kovach Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nature Genetics 36 2004 4 377 381
70. L Bertram M Hiltunen M Parkinson Family-based association between Alzheimer's disease and variants in UBQLN1. New England Journal of Medicine 352 2005 9 884 894
71. T Müller C Langner A Fuchsbichler Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 39 2004 4 963 969
72. F Bardag-Gorce F W van Leeuwen V Nguyen The role of the ubiquitin-proteasome pathway in the formation of Mallory bodies. Experimental and Molecular Pathology 73 2002 2 75 83
73. L Nan Y Wu F Bardag-Gorce p62 is involved in the mechanism of Mallory body formation. Experimental and Molecular Pathology 77 2004 3 168 175
74. P H Reddy reddyh@oshu.edu Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. Journal of Neurochemistry 96 2006 1 1 13
75. P H Reddy M F Beal Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Research Reviews 49 2005 3 618 632
76. U T Brunk ulf.brunk@pat.liu.se A Terman The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. European Journal of Biochemistry 269 2002 8 1996 2002
77. S Urbé M Sachse P E Row The UIM domain of Hrs couples receptor sorting to vesicle formation. Journal of Cell Science 116 2003 20 4169 4179
78. H AJ Alwan E JJ van Zoelen J EM van Leeuwen j.v.leeuwen@sci.kun.nl Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. Journal of Biological Chemistry 278 2003 37 35781 35790
79. P Sanchez G De Carcer I V Sandoval J Moscat jmoscat@mvax.cbm.uam.es M T Diaz-Meco Localization of atypical protein kinase C isoforms into lysosome- targeted endosomes through interaction with p62. Molecular and Cellular Biology 18 1998 5 3069 3080
80. I S Samuels M L Seibenhener K Neidigh M W Wooten Nerve growth factor stimulates the interaction of ZIP/p62 with atypical protein kinase C and targets endosomal localization: evidence for regulation of nerve growth factor-induced differentiation. Journal of Cellular Biochemistry 82 3 2001 452 466
81. T Geetha M W Wooten Association of the atypical protein kinase C-interacting protein p62/ZIP with nerve growth factor receptor TrkA regulates receptor trafficking and Erk5 signaling. Journal of Biological Chemistry 278 2003 7 4730 4739
82. J Lucocq D Walker Evidence for fusion between multilamellar endosomes and autophagosomes in HeLa cells. European Journal of Cell Biology 72 1997 4 307 313
83. T Shintani D J Klionsky klionsky@umich.edu Autophagy in health and disease: a double-edged sword. Science 306 2004 5698 990 995
84. R A Nixon J Wegiel A Kumar Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. Journal of Neuropathology and Experimental Neurology 64 2005 2 113 122
85. J L Webb B Ravikumar J Atkins J N Skepper D C Rubinsztein dcr1000@cus.cam.ac.uk α-synuclein is degraded by both autophagy and the proteasome. Journal of Biological Chemistry 278 2003 27 25009 25013
86. J N Keller jnkell0@pop.uky.edu E Dimayuga Q Chen J Thorpe J Gee Q Ding Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. International Journal of Biochemistry and Cell Biology 36 2004 12 2376 2391
87. G Bjørkøy T Lamark A Brech p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. Journal of Cell Biology 171 2005 4 603 614